IMPEL NEUROPHARMA INC
COM · Common Stock · CUSIP 45258K109
2
institutional holders
-31 vs Q3 2023
2.8m
shares reported held*
$341.0kreported value*
0 new
0 added
0 reduced
31 sold out
net sold ≈ $1.8m (-14.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.12.
Trends to Q4 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2021 | 34 |
| Q3 2021 | 45 |
| Q4 2021 | 46 |
| Q1 2022 | 43 |
| Q2 2022 | 37 |
| Q3 2022 | 40 |
| Q4 2022 | 36 |
| Q1 2023 | 33 |
| Q2 2023 | 33 |
| Q3 2023 | 33 |
| Q4 2023 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2022 | 17 | 20 |
| Q2 2022 | 12 | 29 |
| Q3 2022 | 15 | 11 |
| Q4 2022 | 10 | 20 |
| Q1 2023 | 9 | 12 |
| Q2 2023 | 5 | 7 |
| Q3 2023 | 9 | 11 |
| Q4 2023 | 0 | 31 |
Biggest buyers
| None |
Biggest sellers
| Kohlberg Kravis Roberts & Co. L.P. | Sold out | -4.1m |
| NVP ASSOCIATES, LLC | Sold out | -3.1m |
| 5AM Venture Management, LLC | Sold out | -2.9m |
| Vivo Capital, LLC | Sold out | -2.9m |
| VANGUARD GROUP INC | Sold out | -505.2k |
| LASRY MARC | Sold out | -225.9k |
| DCF Advisers, LLC | Sold out | -178.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -172.2k |
| Bank of New York Mellon Corp | Sold out | -35.3k |
| STATE STREET CORP | Sold out | -25.2k |
Holders, Q4 2023
| Manager | Shares | Change |
|---|---|---|
| venBio Partners LLC 0.05% of their portfolio | 2.8m $340.8k | Unchanged |
| ST GERMAIN D J CO INC 0.00% of their portfolio | 1.5k $185 | Unchanged |